Supported by the National Basic Research Program of China (973 Program,No.2003CB517103);the Natural Science Foundation of Beijing(No.7062058)
The existing efficacy evaluation for coronary heart disease (CHD) angina pectoris does not demonstrate the characteristics and advantages of Chinese medicine (CM), so a new system of efficacy evaluation which can ...